Warhound has emerged with $200 million in funding to genetically engineer and clone working dogs for the US military by 2027.
Backed by industry figures including Ben Lamm and Palmer Luckey, the startup plans to target health conditions in donor breeds while exploring biological enhancements and protective gear.
Warhound has already begun the process of altering genes in cells taken from dogs used by the military, police and rescue services in the United States. These breeds include mainly Malinois, as well as some Labradors and sheepdogs. After the scientists have altered the genes, they plan to proceed with cloning the animals.
Goals and future improvements
Initially, scientists are focusing on reducing the animals' chances of developing health problems that often plague these breeds, such as hip dysplasia and certain types of cancer. In the future, Lamm says other genetic changes could be made to make dogs faster, more agile or have an even better sense of smell.
Anduril will design protective equipment and software for the animals, including goggles, vests and armor. Palmer Luckey is a partner, but neither he nor his company has a financial stake in Warhound. In contrast, Colossal Biosciences owns shares in the company, and Ben Lamm sits on its board of directors.
READ ALSO
Canonical is paving the way for artificial intelligence in Ubuntu
Leadership and next steps
The new company is headed by David Spirk, who previously worked at Palantir. Warhound expects the first genetically modified dogs to be born in early 2027. The animals will then be trained to perform tasks such as bomb detection and search and rescue operations.
G
Hacks.gr on Google
Set it as a preferred source for cybersecurity updates.
Preferred source
